Related Experiment Video
Updated: Sep 12, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Advances and Challenges in Depression Marker Research
Weifeng Jin1, Shuzi Chen1, Dan Li1
1Department of Medical Laboratory, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Abstract:
Depressive disorders diagnosis relies on subjective clinical assessment due to the lack of validated biomarkers. This review synthesizes recent advances in depression biomarkers across genetic, epigenetic, neuroendocrine, neuroimaging, immune/inflammatory, and gut microbiota domains. Literature was systematically searched via PubMed/Web of Science.We analyze mechanisms, highlight challenges (eg, clinical heterogeneity, inadequate animal models), and propose future directions: multidimensional bioinformatics, AI-driven models, RDoC framework implementation, and interdisciplinary collaboration. Critically, our analysis reveals that multimodal integration of biomarkers-rather than single-domain approaches-holds the greatest promise for overcoming diagnostic heterogeneity and guiding personalized interventions. These strategies may revolutionize MDD management through early detection and tailored therapeutics.
Related Concept Videos
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Overview
Long-term Depression
Depressive Disorders: MDD and Dysthymia

